Please assess the completion status of the following clinical trial:

Trial Title: Prevention of Spinal Induced Shivering During CS

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* pregnant women at term,~* ASA status I or II (American Society of Anesthesiologists) physical status class I-II,~* low-risk cesarean section,~* Scheduled for the spinal anesthesia~Exclusion Criteria:~* Pregnant women in labor~* Patients who have the body temperature over 37.3 or less than 37 celsius degree~* Known allergies to the study drugs~* Contraindication to spinal anesthesia

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Granisetron 1 (Type: ACTIVE_COMPARATOR): Intravenous granisetron 1 mg
- Granisetron 0.7 (Type: ACTIVE_COMPARATOR): Intravenous granisetron 0.7 mg
- Placebo (Type: PLACEBO_COMPARATOR): intravenous 0.9% Sodium chloride (2 ml)

Based on this trial design, predict the completion outcome and termination type (if applicable).